Industry Veterans Launch MOMENTUS Biopharma Consulting
Announced in a press release, industry leaders Scott Roberts and John "Zeke" Czekanski have launched MOMENTUS Biopharma Consulting, a strategic consulting firm focused on supporting biopharma companies through the therapeutic lifecycle. The company is headquartered in Lantana, Florida, with an additional office in Boston, Massachusetts.
MOMENTUS aims to integrate artificial intelligence and new technologies with human expertise to offer value-driven strategies for its clients. The firm provides consulting services that combine subject-matter knowledge with flexible, cost-effective solutions.
Roberts, serving as Chief Strategy Officer and Managing Partner, brings over 25 years of experience in healthcare and global value consulting, with previous roles at Biogen, Merck, and Roche. Czekanski, the company's CEO, previously co-founded Citrus Health Group and has held senior positions at Merck & Co., Cardinal Health, and the Fishawack Group of Companies.
The founders stated that MOMENTUS was created to address increasing industry complexity and regulatory challenges by providing targeted insights and strategic guidance to accelerate the approval and adoption of new therapies.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Momentus Technologies Launches AI Sales CRM for Venues
Amigo Rebrands as Concurrence
Thyme Care Raises Over $125 Million and Forms Thyme Companies
Zeit AI raises €5 million for autonomous data engineering agent
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Daily AI Brief: the AI news that matters, in your inbox.